Clinical trial
Randomized Multicentric Phase III Trial Comparing Simple Surgery to Surgery Plus HIPEC (Hyperthermic Intraperitoneal Chemotherapy) With MMC in Colorectal Patients Who Have a High Risk of Developing Colorectal Peritoneal Carcinomatosis
NCT02179489 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Multicentric Phase III Trial Comparing Simple Surgery to Surgery Plus HIPEC (Hyperthermic Intraperitoneal Chemotherapy) With MMC in Colorectal Patients Who Have a High Risk of Developing Colorectal Peritoneal Carcinomatosis
- Lead sponsor
- Zhejiang University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2014
- Completion date
- November 30, 2021
- Enrollment
- 271 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
malignant neoplasm of large intestine tnm staging primary tumor (t) t4, peritoneal carcinomatosis